Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Ropinirole

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Ropinirole

Ayesan Rewane et al.
Free Books & Documents

Excerpt

Ropinirole is a drug that targets D2 receptors to manage Parkinson disease (PD) and restless leg syndrome. As a dopamine agonist, it acts on G-protein-coupled inhibitory neurons, inhibiting adenylyl cyclase and calcium channels while activating potassium channels. This mechanism maximizes the "on" time and minimizes the "off" time associated with disease progression, making ropinirole an attractive option for managing early and advanced-stage PD. Beyond its primary indications, ropinirole has also proved effective in addressing sleep disturbances and nocturnal symptoms linked to PD. This activity explores the applications of ropinirole and discusses its indications, contraindications, mechanism of action, adverse events, and essential considerations when using it as a therapy component.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Ayesan Rewane declares no relevant financial relationships with ineligible companies.

Disclosure: Preeti Patel declares no relevant financial relationships with ineligible companies.

Disclosure: Shivaraj Nagalli declares no relevant financial relationships with ineligible companies.

References

    1. Stocchi F, Radicati FG, Torti M. Drug safety evaluation of ropinirole prolonged release. Expert Opin Drug Saf. 2014 Mar;13(3):383-9. - PubMed
    1. Kaye CM, Nicholls B. Clinical pharmacokinetics of ropinirole. Clin Pharmacokinet. 2000 Oct;39(4):243-54. - PubMed
    1. Muth CC. Restless Legs Syndrome. JAMA. 2017 Feb 21;317(7):780. - PubMed
    1. Lee A, Gilbert RM. Epidemiology of Parkinson Disease. Neurol Clin. 2016 Nov;34(4):955-965. - PubMed
    1. Pahwa R, Lyons KE, Hauser RA. Ropinirole therapy for Parkinson's disease. Expert Rev Neurother. 2004 Jul;4(4):581-8. - PubMed

Publication types

LinkOut - more resources